During the 25th Congress of the European Hematology Association (EHA), the ALL Hub spoke to Claire Roddie, University College London, London, UK. We asked, Is AUTO1 chimeric antigen receptor (CAR) T-cell therapy effective in reducing toxicity and enhancing T-cell activation in ALL?